Each ANDA contained a Paragraph IV certification alleging that patents held by Sepracor covering aspects of the Lunesta drug were invalid or not infringed, according to the suit.

FORBES: Wockhardt Fails To Nix Sepracor's Lunesta Patents

In the first paragraph of its Article IV consultation today, it raises the question of whether it is time to change macroeconomic policies.

BBC: IMF set out a 'Plan B' for George Osborne